1. Leading the science behind obesity

    Learn about our commitment to driving change in how the world sees and treats obesity

  2. Driving innovation to help improve the lives of people living with cardiovascular disease

    See how we're advancing research in cardiovascular disease to address unmet needs

  3. Learn about the safety risks of counterfeit and unapproved compounded drugs that claim to contain semaglutide

Latest news

March 05 2025

Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients

Read more

March 03 2025

Novo Nordisk Launches National "My Ozempic® Era" Campaign Celebrating Stories of Inspirational Ozempic® Patients

Read more

February 21 2025

FDA declares Wegovy® and Ozempic® shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses

Read more

News archive

  1. Our pledge to you: Driving comprehensive, affordable patient access for chronic diseases

    Learn about our initiatives to support patients in need

Career opportunities

Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.

We offer 1062 job opportunities